Evaluating a combined (frequency and percentage) risk expression to communicate information on medicine side effects to patients

International Journal of Pharmacy Practice

Volumn 21, Issue 4, 2013, Pages 226-232

  Knapp, Peter ^a   Gardner, Peter ^b   Mcmillan, Brian ^b   Raynor, David K ^b   Woolf, Elizabeth ^c  

^a UNIVERSITY OF YORK   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

harm; information; medicines; RCT; risk; tamoxifen

Indexed keywords

TAMOXIFEN;

ADOLESCENT; ADULT; AGED; ARTHRALGIA; ARTICLE; CANCER PATIENT; CATARACT; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG EFFECT; DRUG INFORMATION; FEMALE; HOT FLUSH; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; NAUSEA; PATIENT PREFERENCE; PRIORITY JOURNAL; SIDE EFFECT; UNITED KINGDOM; WEIGHT GAIN;

HARM; INFORMATION; MEDICINES; RCT; RISK; TAMOXIFEN;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS, HORMONAL; COMMUNICATION; FEMALE; HUMANS; INTERNET; MALE; MIDDLE AGED; NEOPLASMS; PATIENT EDUCATION AS TOPIC; PATIENT PREFERENCE; RISK; TAMOXIFEN; YOUNG ADULT;

EID: 84880084419     PISSN: 09617671     EISSN: 20427174     Source Type: Journal    
DOI: 10.1111/j.2042-7174.2012.00254.x     Document Type: Article

References (16)

1. Berry DC, et al. What do patients want to know about their medicines? An empirical study. Expert Syst Appl 1995; 8: 419-428.
2. Ziegler DK, et al. How much information about adverse effects of medication do patients want from physicians? Arch Intern Med 2001; 161: 706-713.
3. Fried TR, et al. Effects of benefits and harms on older persons' willingness to take medication for primary cardiovascular prevention. Arch Intern Med 2011; 171: 923-928.
4. Nicolson DJ, et al. Written information about individual medicines for consumers. Cochrane Database Syst Rev 2009; Issue 2. CD002104.
5. European Commission. A Guideline on the Readability of the Label and Package Leaflet of Medicinal Products for Human Use. Brussels: EC Pharmaceuticals Committee, 1998.
6. European Commission. Guideline on the Readability of the Label and Package Leaflet of Medicinal Products for Human Use (Revision 1). Brussels: EC Pharmaceuticals Committee, 2009.
7. Medicines and Healthcare Products Regulatory Agency. Always Read the Leaflet-Getting the Best Information with Every Medicine. London: The Stationery Office, 2005.
8. Berry DC, et al. Provision of information about drug side effects to patients. Lancet 2002; 359: 853-854.
9. Knapp P, et al. Comparison of two methods of presenting risk information to patients about the side effects of medicines. Qual Saf Healthc 2004; 13: 176-180.
10. Knapp P, et al. Perceived risk of medicine side effects in users of a patient information website: A study of the use of verbal descriptors, percentages and natural frequencies. Br J Health Psychol 2009; 14: 579-594.
11. Knapp P, et al. Communicating the risk of side effects to patients: An evaluation of UK regulatory recommendations. Drug Saf 2009; 32: 837-849.
12. Gigerenzer G, Edwards A,. Simple tools for understanding risks: from innumeracy to insight. Br Med J 2004; 327: 741-744.
13. Akl EA, et al. Using alternative statistical formats for presenting risks and risk reductions. Cochrane Database Syst Rev 2011; Issue 3. CD006776.
14. Galesic M, Garcia-Retamero R,. Statistical numeracy for health: A cross-cultural comparison with probabilistic national samples. Arch Intern Med 2010; 170: 462-468.
15. Gardner PH, et al. The effect of numeracy on the comprehension of information about medicines in users of a patient information website. Patient Educ Couns 2011; 83: 398-403.
16. Reyna VF, et al. How numeracy influences risk comprehension and medical decision making. Psychol Bull 2009; 135: 943-973.